A citation-based method for searching scientific literature

Ling-Chuan Guo, Wei-Dong Zhu, Xiang-Yuan Ma, Hao Ni, En-Jian Zhong, Yang W Shao, Jie Yu, Dong-Mei Gu, Shun-Dong Ji, Hao-Dong Xu, Cheng Ji, Jin-Ming Yang, Yi Zhang. Cancer Biol Ther 2019
Times Cited: 5







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Nikita Pozdeyev, Laurie M Gay, Ethan S Sokol, Ryan Hartmaier, Kelsi E Deaver, Stephanie Davis, Jena D French, Pierre Vanden Borre, Daniel V LaBarbera, Aik-Choon Tan,[...]. Clin Cancer Res 2018
164
60

Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy.
Hui Chen, Rajyalakshmi Luthra, Mark J Routbort, Keyur P Patel, Maria E Cabanillas, Russell R Broaddus, Michelle D Williams. Mol Cancer Ther 2018
36
60

Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma.
Abdul K Siraj, Poyil Pratheeshkumar, Sandeep Kumar Parvathareddy, Rong Bu, Tariq Masoodi, Kaleem Iqbal, Maha Al-Rasheed, Fouad Al-Dayel, Saif S Al-Sobhi, Ali S Alzahrani,[...]. Eur J Cancer 2019
11
40

Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
327
40

Targeted next-generation sequencing of cancer-related genes in thyroid carcinoma: A single institution's experience.
Nobuyuki Bandoh, Toshiaki Akahane, Takashi Goto, Michihisa Kono, Haruyuki Ichikawa, Takahiro Sawada, Tomomi Yamaguchi, Hiroshi Nakano, Yumiko Kawase, Yasutaka Kato,[...]. Oncol Lett 2018
14
20

DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
Sandra Rodríguez-Rodero, Agustín F Fernández, Juan Luís Fernández-Morera, Patricia Castro-Santos, Gustavo F Bayon, Cecilia Ferrero, Rocio G Urdinguio, Rocío Gonzalez-Marquez, Carlos Suarez, Iván Fernández-Vega,[...]. J Clin Endocrinol Metab 2013
78
20

Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
Felicitas Thol, Frederik Damm, Andrea Lüdeking, Claudia Winschel, Katharina Wagner, Michael Morgan, Haiyang Yun, Gudrun Göhring, Brigitte Schlegelberger, Dieter Hoelzer,[...]. J Clin Oncol 2011
280
20

Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.
Mei Zhao, Daisuke Sano, Curtis R Pickering, Samar A Jasser, Ying C Henderson, Gary L Clayman, Erich M Sturgis, Thomas J Ow, Reuben Lotan, Thomas E Carey,[...]. Clin Cancer Res 2011
180
20

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
20


Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer.
R L Momparler, D Y Bouffard, L F Momparler, J Dionne, K Belanger, J Ayoub. Anticancer Drugs 1997
176
20

DNMT1, DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population.
Adrianna Mostowska, Stefan Sajdak, Piotr Pawlik, Margarita Lianeri, Paweł P Jagodzinski. Mol Biol Rep 2013
39
20

Gene methylation in thyroid tumorigenesis.
Mingzhao Xing. Endocrinology 2007
127
20

Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.
Abdul K Siraj, Tariq Masoodi, Rong Bu, Shaham Beg, Saif S Al-Sobhi, Fouad Al-Dayel, Mohammed Al-Dawish, Fowzan S Alkuraya, Khawla S Al-Kuraya. Am J Hum Genet 2016
32
20


Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy.
Rakesh Singal, Kavitha Ramachandran, Edna Gordian, Carlos Quintero, Wei Zhao, Isildinha M Reis. Clin Genitourin Cancer 2015
34
20

DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Bong-Kyeong Oh, Haeryoung Kim, Hye-Jung Park, Yhong-Hee Shim, Jinsub Choi, Chanil Park, Young Nyun Park. Int J Mol Med 2007
138
20

Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies.
Gerald S Falchook, Siqing Fu, Aung Naing, David S Hong, Wei Hu, Stacy Moulder, Jennifer J Wheler, Anil K Sood, Ernesto Bustinza-Linares, Kristin L Parkhurst,[...]. Invest New Drugs 2013
34
20

New developments in the diagnosis and treatment of thyroid cancer.
David F Schneider, Herbert Chen. CA Cancer J Clin 2013
173
20

Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study.
Nilofer S Azad, Anthony El-Khoueiry, Jun Yin, Ann L Oberg, Patrick Flynn, Douglas Adkins, Anup Sharma, Daniel J Weisenberger, Thomas Brown, Prakriti Medvari,[...]. Oncotarget 2017
39
20

Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.
Jared A Gollob, Catherine J Sciambi, Bercedis L Peterson, Tina Richmond, Monica Thoreson, Kelly Moran, Holly K Dressman, Jaroslav Jelinek, Jean-Pierre J Issa. Clin Cancer Res 2006
108
20


Demethylating Agents in the Treatment of Cancer.
Paul M Howell, Zixing Liu, Hung T Khong. Pharmaceuticals (Basel) 2010
30
20

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer.
Fang Fang, Curt Balch, Jeanne Schilder, Timothy Breen, Shu Zhang, Changyu Shen, Lang Li, Carol Kulesavage, Anthony J Snyder, Kenneth P Nephew,[...]. Cancer 2010
115
20

Demethylating agents in myeloid malignancies.
Guillermo Garcia-Manero. Curr Opin Oncol 2008
83
20

DNA methylation and personalized medicine.
J Tang, Y Xiong, H-H Zhou, X-P Chen. J Clin Pharm Ther 2014
18
20

DNMT3a expression pattern and its prognostic value in lung adenocarcinoma.
Ryan Edbert Husni, Aya Shiba-Ishii, Shinji Iiyama, Toshihiro Shiozawa, Yunjung Kim, Tomoki Nakagawa, Taiki Sato, Junko Kano, Yuko Minami, Masayuki Noguchi. Lung Cancer 2016
14
20


Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
Prashant Bavi, Zeenath Jehan, Valerie Atizado, Hassan Al-Dossari, Fouad Al-Dayel, Asmah Tulbah, Samir S Amr, Salwa S Sheikh, Adnan Ezzat, Hassan El-Solh,[...]. Cancer Epidemiol Biomarkers Prev 2006
40
20

Epigenetic alternations and cancer chemotherapy response.
Jin-Feng Lv, Lei Hu, Wei Zhuo, Cong-Min Zhang, Hong-Hao Zhou, Lan Fan. Cancer Chemother Pharmacol 2016
18
20


DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer.
Xue-Yuan Cao, Hong-Xi Ma, Yan-Hong Shang, Mei-Shan Jin, Fei Kong, Zhi-Fang Jia, Dong-Hui Cao, Yin-Ping Wang, Jian Suo, Jing Jiang. World J Gastroenterol 2014
34
20

A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies.
Julie Bauman, Claire Verschraegen, Steven Belinsky, Carolyn Muller, Teresa Rutledge, M Fekrazad, Meera Ravindranathan, Sang-Joon Lee, Dennie Jones. Cancer Chemother Pharmacol 2012
34
20


Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin.
Michael J Overman, Van Morris, Helen Moinova, Ganiraju Manyam, Joe Ensor, Michael S Lee, Cathy Eng, Bryan Kee, David Fogelman, Rachna T Shroff,[...]. Oncotarget 2016
32
20

Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors.
Kim Appleton, Helen J Mackay, Ian Judson, Jane A Plumb, Carol McCormick, Gordon Strathdee, Chooi Lee, Sophie Barrett, Sarah Reade, Dalal Jadayel,[...]. J Clin Oncol 2007
181
20

DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia.
Mrinal M Patnaik, Daniela Barraco, Terra L Lasho, Christy M Finke, Curtis A Hanson, Rhett P Ketterling, Naseema Gangat, Ayalew Tefferi. Am J Hematol 2017
45
20

Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer.
Wen-Liang Li, Mei-Sheng Xiao, Deng-Feng Zhang, Dandan Yu, Run-Xiang Yang, Xiao-Yan Li, Yong-Gang Yao. Gene 2014
17
20

The rs1550117 A>G variant in DNMT3A gene promoter significantly increases non-small cell lung cancer susceptibility in a Han Chinese population.
Jingdong Wang, Chade Li, Fengting Wan, Zhou Li, Jingli Zhang, Jiankun Zhang, Xianhong Feng, Liang Tang, Bifeng Chen. Oncotarget 2017
8
20


Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.
Ana Flávia Tibúrcio Ribeiro, Marta Pratcorona, Claudia Erpelinck-Verschueren, Veronika Rockova, Mathijs Sanders, Saman Abbas, Maria E Figueroa, Annelieke Zeilemaker, Ari Melnick, Bob Löwenberg,[...]. Blood 2012
182
20

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Aaron McKenna, Matthew Hanna, Eric Banks, Andrey Sivachenko, Kristian Cibulskis, Andrew Kernytsky, Kiran Garimella, David Altshuler, Stacey Gabriel, Mark Daly,[...]. Genome Res 2010
20

Epigenetics of thyroid cancer and novel therapeutic targets.
Diego Russo, Giuseppe Damante, Efisio Puxeddu, Cosimo Durante, Sebastiano Filetti. J Mol Endocrinol 2011
67
20

MET receptor tyrosine kinase sequence alterations in differentiated thyroid carcinoma.
Veli-Matti Wasenius, Samuli Hemmer, Marja-Liisa Karjalainen-Lindsberg, Nina N Nupponen, Kaarle Franssila, Heikki Joensuu. Am J Surg Pathol 2005
53
20


Cancer microRNAs: from subtype profiling to predictors of response to therapy.
Elcie Chan, Daniel Estévez Prado, Joanne Barnes Weidhaas. Trends Mol Med 2011
52
20

RB1, development, and cancer.
Meenalakshmi Chinnam, David W Goodrich. Curr Top Dev Biol 2011
106
20

The PDCD4/miR-21 pathway in medullary thyroid carcinoma.
Gianmaria Pennelli, Francesca Galuppini, Susi Barollo, Elisabetta Cavedon, Loris Bertazza, Matteo Fassan, Vincenza Guzzardo, Maria Rosa Pelizzo, Massimo Rugge, Caterina Mian. Hum Pathol 2015
47
20

Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.
Caterina Mian, Gianmaria Pennelli, Susi Barollo, Elisabetta Cavedon, Davide Nacamulli, Federica Vianello, Isabella Negro, Giulia Pozza, Isabella Merante Boschin, Maria Rosa Pelizzo,[...]. Eur J Endocrinol 2011
60
20

High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas.
Michele Simbolo, Caterina Mian, Susi Barollo, Matteo Fassan, Andrea Mafficini, Diogo Neves, Maria Scardoni, Gianmaria Pennelli, Massimo Rugge, Maria Rosa Pelizzo,[...]. Virchows Arch 2014
49
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.